Laura Brege serves as Executive at ONYX PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Laura Brege has executed 130 insider transactions totaling $17.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 11, 2025 involved exercising options for 17,000 shares valued at $255.0K.
Laura Brege currently holds 32,703 shares of ONYX PHARMACEUTICALS INC (ONXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laura Brege has been a net seller of ONXX stock. They have purchased $125.0K and sold $17.3M worth of shares.
Laura Brege's most recent insider trade was on Sep 11, 2025, when they sold 17,000 shares at $15.00 per share.
Get notified when new Form 4 filings are submitted
| $74.34 |
| Discretionary |
| Sep 11, 2025 | MIRM | $111.9K | Sale | 1,491 | $75.07 | Discretionary |
| Aug 16, 2024 | PCRX | $12.8K | Purchase | 1,000 | $12.81 | Discretionary |
| Jun 12, 2024 | PCRX | $0 | Award | 5,230 | $N/A | Discretionary |
| May 29, 2024 | ACAD | $0 | Option Exercise | 6,652 | $N/A | Discretionary |
| Jun 14, 2023 | PCRX | $0 | Award | 1,775 | $N/A | Discretionary |
| Jun 12, 2023 | ACAD | $111.9K | Sale | 4,500 | $24.87 | Planned |
| Jun 5, 2023 | PCRX | $23.2K | Sale | 600 | $38.74 | Planned |
| Jun 1, 2023 | ACAD | $0 | Option Exercise | 8,552 | $N/A | Discretionary |
| Apr 3, 2023 | PCRX | $285.0K | Sale | 7,000 | $40.72 | Planned |
| Apr 3, 2023 | PCRX | $209.3K | Option Exercise | 7,000 | $29.90 | Planned |
| Jan 12, 2023 | ACAD | $228.1K | Sale | 12,500 | $18.25 | Discretionary |
| Jan 12, 2023 | ACAD | $212.6K | Option Exercise | 12,500 | $17.01 | Discretionary |
| Jun 8, 2022 | PCRX | $0 | Award | 1,160 | $N/A | Discretionary |
| Jun 7, 2022 | ACAD | $0 | Option Exercise | 6,391 | $N/A | Discretionary |
| Jun 22, 2021 | ACAD | $0 | Option Exercise | 3,059 | $N/A | Discretionary |
| Jun 9, 2021 | PCRX | $0 | Award | 1,066 | $N/A | Discretionary |
| Nov 16, 2020 | PCRX | $791.4K | Sale | 12,000 | $65.95 | Discretionary |
| Nov 16, 2020 | PCRX | $167.8K | Option Exercise | 12,000 | $13.98 | Discretionary |
| Jul 2, 2020 | PTLA | $131.1K | Disposition | 7,281 | $18.00 | Discretionary |
| Jul 2, 2020 | PTLA | $237.5K | Disposition | 13,194 | $18.00 | Discretionary |
| Jun 12, 2020 | PTLA | $0 | Award | 7,281 | $N/A | Discretionary |
| Jun 9, 2020 | PCRX | $0 | Award | 1,260 | $N/A | Discretionary |
| Jun 5, 2020 | PCRX | $102.3K | Sale | 2,100 | $48.70 | Discretionary |
| Jan 7, 2020 | ACAD | $17.5K | Option Exercise | 10,000 | $1.75 | Discretionary |
| Jan 7, 2020 | ACAD | $421.9K | Sale | 10,000 | $42.19 | Discretionary |
| Sep 10, 2019 | MIRM | $112.2K | Purchase | 10,000 | $11.22 | Discretionary |
| Jun 13, 2019 | PTLA | $0 | Award | 4,194 | $N/A | Discretionary |
| Jun 5, 2019 | PCRX | $0 | Award | 4,134 | $N/A | Discretionary |